AI-generated summary
The authors studied blue organic light-emitting diode (bOLED) light on human adipose-derived stem cells in the laboratory, comparing phototoxicity at different light fluences and examining angiogenic properties and intracellular reactive oxygen species. They report that under optimum bOLED conditions, photobiomodulation and angiogenic properties of the cells were enhanced. The findings are described as potentially opening new methods for future ischemic disease treatments.
- Who or what was studied
- Human adipose-derived stem cells (hADSC) studied in vitro
- Limits stated in the abstract
- The study is a cell-culture investigation, so its findings have not been tested in people or animals.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Reactive oxygen species, Light-emitting diode, Photobiomodulation. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.